Long-term oxygen therapy has been proven to improve survival in COPD patients with severely impaired oxygenation. However, does the COPD patient with moderately impaired oxygenation also benefit from supplemental long-term oxygen therapy? The Long-Term Oxygen Treatment Trial (LOTT), a randomized clinical trial published in 2016, was designed to evaluate the efficacy of supplemental oxygen for this patient population. This presentation will discuss the design and results of the multi-center LOTT and the implications on patient care.

Presented by Jerry Krishnan, MD, PhD

This Live AARC webcast is approved for 1.0 CRCE

***To download the abstract of the study that will be discussed please use the link below***

The Long-Term Oxygen Treatment Trial Research Group. A randomized trial of long-term oxygen for COPD with moderate desaturation. NEJM 2016;375(17):1617-1627.

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1604344

This webcast is sponsored by an unrestricted educational grant from ResMed Inc.